Ramipril (AvKARE, Inc.)
Welcome to the PulseAid listing for the Ramipril drug offered from AvKARE, Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AvKARE, Inc. |
NON-PROPRIETARY NAME: | Ramipril |
SUBSTANCE NAME: | RAMIPRIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-03-23 |
END MARKETING DATE: | 0000-00-00 |
Ramipril HUMAN PRESCRIPTION DRUG Details:
Item Description | Ramipril from AvKARE, Inc. |
LABELER NAME: | AvKARE, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2017-03-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42291-692_d5137205-7f71-4b6d-a4a3-bf60440e6390 |
PRODUCT NDC: | 42291-692 |
APPLICATION NUMBER: | ANDA078745 |
Other RAMIPRIL Pharmaceutical Manufacturers / Labelers: